Physician profile
Jay Kumar
NPI 1205269065
$1,469.09
in general payments reported to CMS, 2019-2025
9 companies · $502 in 2025
The $502 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.68 · 2021: $366 · 2023: $271 · 2024: $231 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731 · Travel and Lodging: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.75 |
| Travel and Lodging | $272.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $455.99 | 2021-2025 | Eterna |
| Bioventus LLC | $272.96 | 2025 | Stimrouter Implantable Kit |
| Nuvasive, INC. | $270.71 | 2023 | Maxcess, Reline, Xlif |
| Medtronic, INC. | $191.97 | 2024-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $130.43 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $99.68 | 2019 | |
| Exact Sciences Corporation | $17.64 | 2024 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $15.19 | 2021 | |
| Nalu Medical, INC. | $14.52 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.